Francesco Raspagliesi Selected Research

olaparib

11/2021	Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
1/2021	Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
1/2020	Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
1/2018	Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Raspagliesi Research Topics

Disease

74	Neoplasms (Cancer) 04/2024 - 07/2003
68	Ovarian Neoplasms (Ovarian Cancer) 07/2024 - 07/2003
62	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2002
27	Endometrial Neoplasms (Endometrial Cancer) 04/2024 - 12/2008
14	Ovarian Epithelial Carcinoma 01/2022 - 08/2004
13	Carcinoma (Carcinomatosis) 02/2024 - 01/2002
8	Leiomyosarcoma 01/2020 - 12/2011
7	Adenocarcinoma 03/2024 - 08/2004
7	Sarcoma (Soft Tissue Sarcoma) 06/2018 - 12/2011
6	Infections 01/2023 - 03/2017
5	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2013
4	Disease Progression 12/2023 - 10/2016
4	Uterine Cervical Dysplasia 11/2023 - 01/2019
4	Carcinosarcoma 01/2023 - 09/2014
4	Hypertension (High Blood Pressure) 01/2021 - 07/2014
4	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
4	Ascites 01/2019 - 07/2014
3	Papillomavirus Infections 01/2023 - 03/2017
3	Nausea 01/2023 - 01/2017
3	COVID-19 01/2022 - 07/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 01/2014
3	Lymphatic Metastasis 09/2020 - 12/2008
3	Neutropenia 01/2019 - 07/2014
2	Fallopian Tube Neoplasms 07/2024 - 02/2024
2	Fatigue 01/2023 - 05/2015
2	Vulvar Neoplasms (Vulvar Cancer) 11/2022 - 01/2014
2	Vomiting 06/2019 - 01/2017
2	Smooth Muscle Tumor 01/2018 - 05/2016
2	Myoma 01/2017 - 07/2016
2	Intraoperative Complications 05/2016 - 08/2006
2	Hemorrhage 07/2014 - 07/2009
1	Drug-Related Side Effects and Adverse Reactions 02/2024

Drug/Important Bio-Agent (IBA)

21	PlatinumIBA 02/2024 - 07/2003
21	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 01/2004
15	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 02/2004
11	Bevacizumab (Avastin)FDA Link 08/2023 - 07/2013
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
7	Cisplatin (Platino)FDA LinkGeneric 09/2014 - 02/2007
6	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 01/2019
5	TrabectedinIBA 02/2024 - 12/2011
5	pembrolizumabIBA 11/2023 - 01/2021
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 06/2017
4	Gemcitabine FDA Link 02/2024 - 01/2004
4	Choline (Choline Chloride)IBA 12/2023 - 06/2011
4	AntigensIBA 12/2023 - 07/2017
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2015
4	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
4	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2011
4	olaparibIBA 11/2021 - 01/2018
4	Angiogenesis InhibitorsIBA 06/2018 - 05/2015
3	liposomal doxorubicin (Doxil)FDA Link 02/2024 - 08/2019
3	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2023 - 02/2018
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2011
3	lenvatinibIBA 01/2023 - 01/2021
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 01/2015
3	Technetium (Technetium 99m)IBA 01/2020 - 02/2008
3	Ifosfamide FDA LinkGeneric 09/2014 - 12/2011
2	AfatinibIBA 04/2024 - 11/2019
2	copanlisibIBA 04/2024 - 11/2019
2	Topotecan (Hycamtin)FDA LinkGeneric 02/2024 - 11/2010
2	niraparibIBA 01/2024 - 08/2023
2	selinexorIBA 12/2023 - 12/2023
2	dostarlimabIBA 08/2023 - 01/2023
2	Monoclonal AntibodiesIBA 08/2023 - 07/2013
2	LigandsIBA 01/2021 - 10/2015
2	Alanine Transaminase (SGPT)IBA 01/2021 - 05/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 05/2015
2	AnthracyclinesIBA 01/2020 - 12/2011
2	glycoprotein CX 1IBA 01/2020 - 07/2009
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2014
2	pazopanib FDA Link 08/2017 - 05/2015
2	trebananibIBA 10/2016 - 07/2014
2	Coloring Agents (Dyes)IBA 02/2008 - 08/2004
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 02/2007 - 08/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2024

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 02/2024 - 07/2003
38	Hysterectomy 04/2024 - 09/2003
28	Therapeutics 04/2024 - 07/2003
24	Neoadjuvant Therapy 01/2024 - 01/2002
23	Lymph Node Excision (Lymph Node Dissection) 02/2024 - 09/2003
15	Minimally Invasive Surgical Procedures 01/2023 - 05/2017
12	Radiotherapy 07/2024 - 01/2002
9	Immunotherapy 08/2023 - 01/2019
7	Cytoreduction Surgical Procedures 12/2021 - 01/2016
6	Conservative Treatment 03/2024 - 12/2003
6	Morcellation 02/2018 - 02/2016
3	Adjuvant Chemotherapy 01/2021 - 11/2016
3	Laparotomy 01/2021 - 01/2017
3	Lasers (Laser) 12/2020 - 01/2018
3	Operative Surgical Procedures 11/2020 - 11/2012
3	Blood Transfusion (Blood Transfusions) 02/2017 - 05/2016
2	Salpingo-oophorectomy 04/2024 - 10/2016
2	Precision Medicine 01/2023 - 12/2022
2	Adjuvant Radiotherapy 11/2022 - 12/2015
2	Colpotomy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2019 - 03/2017
2	Investigational Therapies (Experimental Therapy) 01/2017 - 12/2011
2	Ovariectomy (Oophorectomy) 10/2014 - 01/2013
1	Heavy Ion Radiotherapy 07/2024
1	Re-Irradiation 07/2024